$PLTK
Playtika Holding Corp.

2023 Q3 Form 10-Q Financial Statement

#000182801623000030 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $630.1M $642.8M
YoY Change -2.73% -2.55%
Cost Of Revenue $173.9M $188.0M
YoY Change -4.35% 1.02%
Gross Profit $456.2M $454.8M
YoY Change -2.1% -3.95%
Gross Profit Margin 72.4% 70.75%
Selling, General & Admin $222.4M $215.3M
YoY Change 1.32% -16.23%
% of Gross Profit 48.75% 47.34%
Research & Development $102.2M $100.3M
YoY Change -11.21% -19.89%
% of Gross Profit 22.4% 22.05%
Depreciation & Amortization $28.70M $48.20M
YoY Change -27.53% 13.15%
% of Gross Profit 6.29% 10.6%
Operating Expenses $324.6M $315.6M
YoY Change -2.99% -17.43%
Operating Profit $90.00M $139.2M
YoY Change -31.51% 52.46%
Interest Expense $39.50M $35.80M
YoY Change 25.4% 38.22%
% of Operating Profit 43.89% 25.72%
Other Income/Expense, Net -$300.0K $0.00
YoY Change 200.0% -100.0%
Pretax Income $64.80M $116.1M
YoY Change -39.5% 68.51%
Income Tax $26.90M $40.40M
% Of Pretax Income 41.51% 34.8%
Net Earnings $37.90M $75.70M
YoY Change -44.43% 107.97%
Net Earnings / Revenue 6.01% 11.78%
Basic Earnings Per Share $0.10 $0.21
Diluted Earnings Per Share $0.10 $0.21
COMMON SHARES
Basic Shares Outstanding 366.5M shares 365.7M shares
Diluted Shares Outstanding 367.6M shares 366.4M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $878.2M $955.1M
YoY Change -30.05% -23.04%
Cash & Equivalents $878.2M $955.1M
Short-Term Investments
Other Short-Term Assets $121.4M $110.1M
YoY Change 8.1% -6.06%
Inventory
Prepaid Expenses
Receivables $168.3M $159.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.168B $1.225B
YoY Change -21.92% -17.61%
LONG-TERM ASSETS
Property, Plant & Equipment $109.5M $112.9M
YoY Change 1.2% 1.8%
Goodwill $1.005B $813.2M
YoY Change 25.31% 0.42%
Intangibles $303.6M $313.6M
YoY Change -18.95% -20.59%
Long-Term Investments $54.10M $54.10M
YoY Change 96.01% 137.28%
Other Assets $160.7M $157.4M
YoY Change 306.84% 428.19%
Total Long-Term Assets $1.810B $1.620B
YoY Change 20.83% 6.63%
TOTAL ASSETS
Total Short-Term Assets $1.168B $1.225B
Total Long-Term Assets $1.810B $1.620B
Total Assets $2.978B $2.845B
YoY Change -0.53% -5.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $38.20M $41.30M
YoY Change -4.02% -16.23%
Accrued Expenses $93.60M $93.20M
YoY Change -41.94% -39.99%
Deferred Revenue $46.90M $44.60M
YoY Change 50.32% 45.75%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $16.90M $11.70M
YoY Change 36.29% -5.65%
Total Short-Term Liabilities $400.6M $410.6M
YoY Change -23.83% -33.39%
LONG-TERM LIABILITIES
Long-Term Debt $2.402B $2.406B
YoY Change -0.49% -0.48%
Other Long-Term Liabilities $247.6M $245.4M
YoY Change 180.73% 140.12%
Total Long-Term Liabilities $2.650B $2.651B
YoY Change 9.76% 9.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $400.6M $410.6M
Total Long-Term Liabilities $2.650B $2.651B
Total Liabilities $3.260B $3.190B
YoY Change 5.77% -0.01%
SHAREHOLDERS EQUITY
Retained Earnings -$944.9M -$982.8M
YoY Change -23.19% -24.3%
Common Stock $4.100M $4.100M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$281.9M -$344.9M
YoY Change
Total Liabilities & Shareholders Equity $2.978B $2.845B
YoY Change -0.53% -5.36%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $37.90M $75.70M
YoY Change -44.43% 107.97%
Depreciation, Depletion And Amortization $28.70M $48.20M
YoY Change -27.53% 13.15%
Cash From Operating Activities $108.8M $207.0M
YoY Change 44.68% 13.11%
INVESTING ACTIVITIES
Capital Expenditures $21.70M $16.70M
YoY Change -211.86% -159.01%
Acquisitions
YoY Change
Other Investing Activities -$160.6M -$900.0K
YoY Change -327.8% -100.64%
Cash From Investing Activities -$182.3M -$17.60M
YoY Change -456.75% -115.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -700.0K -5.300M
YoY Change -97.78% -1.85%
NET CHANGE
Cash From Operating Activities 108.8M 207.0M
Cash From Investing Activities -182.3M -17.60M
Cash From Financing Activities -700.0K -5.300M
Net Change In Cash -74.20M 184.1M
YoY Change -178.35% -36.65%
FREE CASH FLOW
Cash From Operating Activities $108.8M $207.0M
Capital Expenditures $21.70M $16.70M
Free Cash Flow $87.10M $190.3M
YoY Change -7.93% -9.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Derivative Asset Current Statement Of Financial Position Extensible Enumeration
DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q2 us-gaap Derivative Asset Current Statement Of Financial Position Extensible Enumeration
DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2022Q4 us-gaap Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4 us-gaap Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q2 us-gaap Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2023Q2 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2023Q2 us-gaap Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
245400000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
252100000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
94900000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
94500000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
33400000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
46600000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3190100000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3266200000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1600000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1600000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
366300000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
366300000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
363600000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
4100000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4100000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
51800000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
51800000 shares
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
603500000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
603500000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1209800000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1155800000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
27500000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17600000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-982800000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1142600000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-344900000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-568600000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2845200000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2697600000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
642800000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
659600000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
188000000.0 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
125200000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
141200000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
151800000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
74100000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
105200000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
503600000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
568300000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1007400000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1124800000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
139200000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
91300000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
291600000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
211700000 usd
CY2023Q2 playtika Interest Expense And Other Net
InterestExpenseAndOtherNet
23100000 usd
CY2022Q2 playtika Interest Expense And Other Net
InterestExpenseAndOtherNet
22400000 usd
playtika Interest Expense And Other Net
InterestExpenseAndOtherNet
51700000 usd
playtika Interest Expense And Other Net
InterestExpenseAndOtherNet
49900000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
116100000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
68900000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
239900000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
161800000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40400000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32500000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42200000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
75700000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
36400000 usd
us-gaap Net Income Loss
NetIncomeLoss
159800000 usd
us-gaap Net Income Loss
NetIncomeLoss
119600000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-200000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-10000000.0 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2900000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-13300000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
14800000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-5900000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
7000000.0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14600000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-15900000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
90300000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
412400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
365300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
412200000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
366400000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
412800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
365800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
412800000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-568600000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
84100000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1300000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4700000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-460700000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
75700000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
600000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14600000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-344900000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-377700000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
83200000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40500000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1400000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15400000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-184100000 usd
us-gaap Net Income Loss
NetIncomeLoss
159800000 usd
us-gaap Net Income Loss
NetIncomeLoss
119600000 usd
us-gaap Depreciation
Depreciation
22100000 usd
us-gaap Depreciation
Depreciation
22000000.0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
65200000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
60100000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
54500000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
75200000 usd
playtika Amortization And Write Off Of Loan Discount
AmortizationAndWriteOffOfLoanDiscount
3400000 usd
playtika Amortization And Write Off Of Loan Discount
AmortizationAndWriteOffOfLoanDiscount
3900000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-9000000.0 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
7800000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
8300000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3100000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9400000 usd
playtika Non Cash Lease Expense Income
NonCashLeaseExpenseIncome
0 usd
playtika Non Cash Lease Expense Income
NonCashLeaseExpenseIncome
6800000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18400000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13500000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-16200000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
32600000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9400000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4100000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-55000000.0 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-10000000.0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
227500000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
241100000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9200000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29500000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
18600000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
23700000 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
4100000 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
4000000.0 usd
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
0 usd
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-24800000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
29900000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1100000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5000000.0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33000000.0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67300000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
9500000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
9500000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1900000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2100000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11400000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11600000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3600000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13600000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
186700000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
148600000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
770400000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1019000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
957100000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1167600000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
90800000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
78700000 usd
playtika Cash Paid For Interest
CashPaidForInterest
73400000 usd
playtika Cash Paid For Interest
CashPaidForInterest
45000000.0 usd
playtika Cash Received For Interest
CashReceivedForInterest
9700000 usd
playtika Cash Received For Interest
CashReceivedForInterest
2600000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13100000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
30800000 usd
us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
0 usd
us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
11400000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1400000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1400000 usd
us-gaap Use Of Estimates
UseOfEstimates
Use of estimatesThe preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of credit risk and significant customers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially expose the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, accounts receivable and derivative contracts. The Company’s investment policy imposes certain maturity limits on the Company’s portfolio and restricts the permitted investments to the purchase of bank deposits and highly rated fixed income securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apple, Facebook and Google are significant distribution, marketing, promotion and payment platforms for the Company's games. A significant portion of the Company’s revenues has been generated from players who accessed the Company's games through these platforms. Therefore, the Company's accounts receivable are derived mainly from sales through these </span></div>three platforms. Accounts receivable are recorded at their transaction amounts and do not bear interest. The Company performs ongoing credit evaluations of its customers.
playtika Number Of Distribution Marketing Promotion And Payment Platforms
NumberOfDistributionMarketingPromotionAndPaymentPlatforms
3 platform
CY2023Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
9700000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
130100000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
170300000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
93200000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
110100000 usd
CY2023Q2 playtika Media Buy Expenses Current
MediaBuyExpensesCurrent
56000000.0 usd
CY2022Q4 playtika Media Buy Expenses Current
MediaBuyExpensesCurrent
41300000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
700000 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
21.19
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
44600000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
38600000 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
16400000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
24900000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
340300000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
385200000 usd
CY2023Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2417500000 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2457300000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2423600000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
11700000 usd
CY2023Q2 playtika Debt Instrument Face Amount Current Portion
DebtInstrumentFaceAmountCurrentPortion
19000000.0 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
12400000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2405800000 usd
CY2023Q2 playtika Debt Instrument Face Amount Net Current Portion
DebtInstrumentFaceAmountNetCurrentPortion
2438300000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2411200000 usd
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
39800000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
43200000 usd
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
39235665 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
16996563 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3400000 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.08
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.29
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1700000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
20.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1800000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.76
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
500000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
9.72
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
26100000 usd
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
36100000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
55900000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
76600000 usd
CY2023Q2 playtika Share Based Compensation Expense Net Of Amounts Capitalized
ShareBasedCompensationExpenseNetOfAmountsCapitalized
25300000 usd
CY2022Q2 playtika Share Based Compensation Expense Net Of Amounts Capitalized
ShareBasedCompensationExpenseNetOfAmountsCapitalized
35400000 usd
playtika Share Based Compensation Expense Net Of Amounts Capitalized
ShareBasedCompensationExpenseNetOfAmountsCapitalized
54500000 usd
playtika Share Based Compensation Expense Net Of Amounts Capitalized
ShareBasedCompensationExpenseNetOfAmountsCapitalized
75200000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
800000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
700000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1400000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1400000 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2457300000 usd
CY2023Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
2383700000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2466800000 usd
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
2262500000 usd
playtika Number Of Demand Received
NumberOfDemandReceived
7 demand
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
642800000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
659600000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1299000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1336500000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
642800000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
659600000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1299000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1336500000 usd
playtika Contract Receivable Collection Period
ContractReceivableCollectionPeriod
P45D
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
159800000 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
141100000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
12300000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10800000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44600000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
38600000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9600000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
31400000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q2 playtika Long Lived Assets And Deferred Tax Assets Net
LongLivedAssetsAndDeferredTaxAssetsNet
221100000 usd
CY2022Q4 playtika Long Lived Assets And Deferred Tax Assets Net
LongLivedAssetsAndDeferredTaxAssetsNet
229900000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
35800000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
25900000 usd
us-gaap Interest Expense
InterestExpense
73800000 usd
us-gaap Interest Expense
InterestExpense
49600000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
10300000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2500000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
18100000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3300000 usd
CY2023Q2 playtika Foreign Currency Translation Differences
ForeignCurrencyTranslationDifferences
2400000 usd
CY2022Q2 playtika Foreign Currency Translation Differences
ForeignCurrencyTranslationDifferences
1100000 usd
playtika Foreign Currency Translation Differences
ForeignCurrencyTranslationDifferences
4200000 usd
playtika Foreign Currency Translation Differences
ForeignCurrencyTranslationDifferences
-2400000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-100000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-200000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1200000 usd
CY2023Q2 playtika Interest Expense And Other Net
InterestExpenseAndOtherNet
23100000 usd
CY2022Q2 playtika Interest Expense And Other Net
InterestExpenseAndOtherNet
22400000 usd
playtika Interest Expense And Other Net
InterestExpenseAndOtherNet
51700000 usd
us-gaap Net Income Loss
NetIncomeLoss
119600000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
365900000 shares
playtika Interest Expense And Other Net
InterestExpenseAndOtherNet
49900000 usd
CY2023Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
116100000 usd
CY2022Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
68900000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
239900000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
161800000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40400000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32500000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42200000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.348
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.472
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.334
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261
CY2023Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-2900000 usd
CY2023Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-1800000 usd
CY2023Q2 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
17900000 usd
CY2023Q2 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-3300000 usd
CY2022Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
14700000 usd
CY2022Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
700000 usd
CY2022Q2 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-17100000 usd
CY2022Q2 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
1200000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
75700000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
36400000 usd
us-gaap Net Income Loss
NetIncomeLoss
159800000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
412400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
365300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
412200000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
500000 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
400000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
500000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
600000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
366400000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
412800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
365800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
412800000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13000000.0 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24800000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14800000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26700000 shares
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001828016-23-000030-index-headers.html Edgar Link pending
0001828016-23-000030-index.html Edgar Link pending
0001828016-23-000030.txt Edgar Link pending
0001828016-23-000030-xbrl.zip Edgar Link pending
a2023q2-ex311xceo302cert.htm Edgar Link pending
a2023q2-ex312xcfo302cert.htm Edgar Link pending
a2023q2-ex321xceo906cert.htm Edgar Link pending
a2023q2-ex322xcfo906cert.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
playtika-20230630.htm Edgar Link pending
playtika-20230630.xsd Edgar Link pending
playtika-thirdamendmentter.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
playtika-20230630_lab.xml Edgar Link unprocessable
playtika-20230630_pre.xml Edgar Link unprocessable
playtika-20230630_cal.xml Edgar Link unprocessable
playtika-20230630_def.xml Edgar Link unprocessable
playtika-20230630_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable